Advent Pharma Ltd. (DSE: ADVENT)
Bangladesh
· Delayed Price · Currency is BDT 24.00
+0.50 (2.13%)
At close: Sep 12, 2024
Advent Pharma Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 11, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2016 |
| Market Capitalization | 2,235 | 2,459 | 2,338 | 2,274 | 1,893 | 2,543 | Upgrade
|
| Market Cap Growth | 15.42% | 5.18% | 2.82% | 20.13% | -25.58% | 8.39% | Upgrade
|
| Enterprise Value | 2,307 | 2,530 | 2,392 | 2,285 | 1,887 | 2,473 | Upgrade
|
| Last Close Price | 24.00 | 26.17 | 24.66 | 23.80 | 19.81 | 26.42 | Upgrade
|
| PE Ratio | 24.19 | 24.71 | 23.55 | 19.52 | 15.76 | 15.53 | Upgrade
|
| PS Ratio | 3.93 | 4.41 | 4.41 | 4.51 | 3.54 | 4.22 | Upgrade
|
| PB Ratio | 1.52 | 1.76 | 1.78 | 1.84 | 1.69 | 2.50 | Upgrade
|
| P/FCF Ratio | 165.81 | 958.68 | -202.30 | -618.83 | -44.71 | -37.01 | Upgrade
|
| P/OCF Ratio | 11.18 | 11.98 | 13.02 | 12.60 | 11.13 | 12.43 | Upgrade
|
| EV/Sales Ratio | 4.06 | 4.53 | 4.51 | 4.54 | 3.53 | 4.11 | Upgrade
|
| EV/EBITDA Ratio | 11.32 | 13.05 | 13.66 | 13.09 | 10.01 | 10.43 | Upgrade
|
| EV/EBIT Ratio | 17.86 | 18.69 | 17.93 | 16.75 | 12.14 | 11.64 | Upgrade
|
| EV/FCF Ratio | 171.13 | 986.61 | -206.97 | -621.92 | -44.58 | -35.99 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.37 | 0.37 | 0.36 | 0.34 | 0.26 | 0.14 | Upgrade
|
| Debt / FCF Ratio | 5.64 | 27.91 | -5.53 | -16.31 | -1.16 | -0.50 | Upgrade
|
| Asset Turnover | 0.31 | 0.33 | 0.34 | 0.35 | 0.41 | 0.54 | Upgrade
|
| Inventory Turnover | 4.72 | 4.16 | 3.96 | 4.02 | 4.43 | 4.73 | Upgrade
|
| Quick Ratio | 0.62 | 0.62 | 0.71 | 1.03 | 1.24 | 1.63 | Upgrade
|
| Current Ratio | 1.07 | 1.15 | 1.38 | 1.72 | 2.01 | 2.69 | Upgrade
|
| Return on Equity (ROE) | 6.46% | 7.27% | 7.66% | 9.65% | 10.94% | 16.74% | Upgrade
|
| Return on Assets (ROA) | 4.40% | 4.93% | 5.27% | 5.90% | 7.53% | 11.96% | Upgrade
|
| Return on Capital (ROIC) | 5.35% | 5.94% | 6.24% | 6.92% | 8.74% | 13.42% | Upgrade
|
| Earnings Yield | 4.13% | 4.01% | 4.17% | 5.00% | 6.19% | 6.23% | Upgrade
|
| FCF Yield | 0.60% | 0.10% | -0.49% | -0.16% | -2.24% | -2.70% | Upgrade
|
| Dividend Yield | 0.83% | 0.76% | 0.81% | 0.82% | - | 0.61% | Upgrade
|
| Payout Ratio | 9.29% | 8.93% | 22.79% | 7.11% | 7.44% | 3.45% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | -22.72% | Upgrade
| |
| Total Shareholder Return | 0.83% | 0.76% | 0.81% | 0.82% | - | -22.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.